About NeuroLeap
NeuroLeap is a company based in Mumbai (India) founded in 2017 by Kumaar Bagrodia. NeuroLeap has raised $46.02 thousand across 1 funding round from investors including Rajashree Birla, Sminu Jindal and Shripriya Jaipuria. NeuroLeap offers products and services including Brain Assessment and Brain Enhancement Program. NeuroLeap operates in a competitive market with competitors including MapHabit, MindPortal, Rhaeos, Ixana and Neurable, among others.
- Headquarter Mumbai, India
- Founders Kumaar Bagrodia
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aditri Neuroscience Private Limited
- Date of Incorporation 08 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$85.91 K (USD)110.04as on Mar 31, 2022
-
Net Profit
$6.19 K (USD)1524.74as on Mar 31, 2022
-
EBITDA
$21.67 K (USD)105.48as on Mar 31, 2022
-
Total Equity Funding
$46.02 K (USD)
in 1 rounds
-
Latest Funding Round
$46.02 K (USD), Angel Round
Aug 28, 2019
-
Investors
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroLeap
NeuroLeap offers a comprehensive portfolio of products and services, including Brain Assessment and Brain Enhancement Program.
Non-invasive service to evaluate subconscious brain patterns.
Sessions to improve brain functions and reduce mental health symptoms.
Funding Insights of NeuroLeap
NeuroLeap has successfully raised a total of $46.02K through 1 strategic funding round. The most recent funding activity was a Angel Round of $46.02 thousand completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NeuroLeap
NeuroLeap has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Rajashree Birla, Sminu Jindal and Shripriya Jaipuria.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
RB
Rajashree Birla |
-
|
Locked | Locked | Locked |
|
SJ
Sminu Jindal |
-
|
Locked | Locked | Locked |
|
SJ
Shripriya Jaipuria |
-
|
Locked | Locked | Locked |
Investor details for NeuroLeap
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroLeap
Investment portfolio details for NeuroLeap
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroLeap
Detailed financials for NeuroLeap
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuroleap Comparisons
Peer comparison for NeuroLeap
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroLeap
NeuroLeap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MapHabit, MindPortal, Rhaeos, Ixana and Neurable, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable devices and app are provided for mental disorder support.
|
|
| Locked | Locked | Locked |
A wearable device for brain analysis and assessment is provided.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
|
| Locked | Locked | Locked |
An AR-based headset for personal assistance is developed.
|
|
| Locked | Locked | Locked |
Brain-computer interface technology is developed for everyday devices.
|
|
| Locked | Locked | Locked |
An AI and AR application for speech-impaired users is developed.
|
Detailed competitors of NeuroLeap
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuroleap
Complete news archive for NeuroLeap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroLeap
NeuroLeap was founded in 2017 and raised its 1st funding round 2 years after it was founded.
NeuroLeap is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Kumaar Bagrodia is the current CEO of NeuroLeap. They have also founded this company.
NeuroLeap is a funded company, having raised a total of $46.02K across 1 funding round to date.
Annual revenue of NeuroLeap is $85.91K as on Mar 31, 2022.
NeuroLeap was founded in 2017 in Mumbai, India, as a provider of software focused on brain assessment within the neurotechnology sector. Non-invasive sensors are placed on the head to capture brainwaves, enabling the generation of reports on cognitive functions including attention, memory, mood, executive abilities, learning, and salience detection. Operations center on software development and data analysis for practical brain performance insights.
NeuroLeap offers Brain Assessment and Brain Enhancement Program.
NeuroLeap has 3 investors. Key investors include Rajashree Birla, Sminu Jindal, and Shripriya Jaipuria.
The valuation of NeuroLeap is $2.85M as of Aug 2019.